B-RAF with PLX4032

From Proteopedia
Revision as of 20:32, 7 October 2010 by Jens Hemmingsen (talk | contribs)
Jump to navigation Jump to search

B-RAF with PLX4032B-RAF with PLX4032

PLX4032 is a newly synthesized drug that is being used to treat malignant melanoma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.







<script>connect(atomno=1127)(atomno=4025)HBOND</script>




testcaption

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Jens Hemmingsen, J.D. Woodruff, Michal Harel